INTRODUCTION & OBJECTIVES: To compare clinical intra and early postoperative outcomes between thulium laser transurethralenucleation of the prostate (ThuLEP) and transurethral bipolar resection of the prostate (TURIS) for treating benign prostatic hyperplasia(BPH) in a prospective randomized trial.MATERIAL & METHODS: The study randomized 208 consecutive patients with BPH to ThuLEP (n = 102) or TURIS (n =106). For allpatients were evaluated preoperatively with regards to blood loss, catheterization time, irrigation volume, hospital stay and operative time.At 3 months after surgery they were also evaluated by International Prostate Symptom Score (IPSS), maximum flow rate (Qmax), andpostvoid residual urine volume (PVR).RESULTS: The patients in each study arm each showed no significant difference in preoperative parameters. Compared with TURIS,ThuLEP had same operative time (53.69±31.44 vs 61.66±18.70 minutes, P = .123) but resulted in less hemoglobin decrease (0.45 vs 2.83g/dL, P = .005). ThuLEP also needed less catheterization time (1.3 vs 4.8 days, P = .011), irrigation volume (29.4 vs 69.2 L, P = .002), andhospital stay (1.7 vs 5.2 days, P = .016). During the 3 months of follow-up, the procedures did not demonstrate a significant difference inQmax, IPSS, PVR, and QOLS.CONCLUSIONS: ThuLEP and TURIS both relieve lower urinary tract symptoms equally, with high efficacy and safety. ThuLEP wasstatistically superior to TURIS in blood loss, catheterization time, irrigation volume, hospital stay and in operation time. However,procedures did not differ significantly in Qmax, IPSS, PVR, and QOLS through 3 months of follow-up.
|Titolo:||THULIUM LASER ENUCLEATION (THULEP) VERSUS TRANSURETHRAL RESECTION OF THE PROSTATE IN SALINE (TURIS): A RANDOMIZED PROSPECTIVE TRIAL TO COMPARE INTRA AND EARLY POSTOPERATIVE OUTCOMES|
|Data di pubblicazione:||2016|
|Appare nelle tipologie:||1.5 Abstract in rivista|